by This fall and winter, Ontario, Quebec and Nunavut will offer nirsevimab — approved by Health Canada in the spring of 2023 — to all babies going through their first RSV season. This fall and winter, Ontario, Quebec and Nunavut will offer nirsevimab — approved by Health Canada in the spring of 2023 — to all babies going through their first RSV season. Read More
